Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of Inactivated Quadrivalent Influenza Vaccine in Healthy Adults
NCT02269007Phase 1Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- May 2015
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of quadrivalent split influenza virus vaccine in influenza, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoint: Incidence of solicited adverse reactions (systemic and local). Started May 2015; status: completed.
02
Drugs
quadrivalent split influenza virus vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02269007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269007.